MedTrace Logo

Smart Measurement of Circulating Tumor DNA

NCT06989814 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-08-11

No results posted yet for this study

Summary

The goal of this study is to develop a blood-test which can detect colorectal cancer in early stages.

Participants will be asked to take an extra blood test, which will be analyzed further in the lab.

Conditions

  • Colorectal Neoplasms
  • Colorectal Neoplasms Malignant
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • Hereditary Nonpolyposis Colon Cancer

Interventions

DIAGNOSTIC_TEST

Blood Product

An (extra) blood test will be done on participants. This will be analyzed for circulating tumor DNA (ctDNA) via a multi-omics approach.

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • Leiden University Medical Center

    collaborator OTHER

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Anja Wagner, Dr. · Erasmus Medical Center

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-16
Primary Completion
2026-10-01
Completion
2027-02-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989814 on ClinicalTrials.gov